Neuren Pharmaceuticals Secures AU$13 Million Royalty From Neurological Therapy in Q2
Neuren Pharmaceuticals Secures AU$13 Million Royalty From Neurological Therapy in Q2
Neuren製藥公司在第二季度從神經治療中獲得了1300萬澳元的版稅
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間